Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Group

Der Cherng Liang,Iou-Jih Hung,Chao-Ping Yang,Kai-Hsin Lin,Jiann Shiuh Chen,Hsiao Tc,Tai-Tsung Chang,Ching-Hon Pui,Lee Ch,K-S Lin

Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Group

1999

Der Cherng Liang
Iou-Jih Hung
Chao-Ping Yang
Kai-Hsin Lin
Jiann Shiuh Chen
Hsiao Tc
Tai-Tsung Chang
Ching-Hon Pui
Lee Ch
K-S Lin

Unexpected mortality from the use of E. coli L -asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology Group

Keywords:

Cancer research
Remission Induction Therapy
INDUCTION TREATMENT
Oncology
Acute lymphocytic leukemia
Pediatric oncology
Asparaginase
Chemotherapy
Complication
Medicine
Childhood Acute Lymphoblastic Leukemia
Internal medicine
Immunology
Etoposide
Gastroenterology
Prednisolone
Cytarabine
Surgery
Vincristine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations